Henlius' Serplulimab (anti-PD-1 mAb) Granted Breakthrough Therapy Designation by China NMPA for Neo-/Adjuvant Treatment for Gastric Cancer
The first CDE-designated Breakthrough Therapy for perioperative gastric cancer, promising accelerated patient access. The world's first gastric cancer perioperative regimen replacing chemotherapy with immunotherapy alone in the adjuvant setting has...
Rare Rolex Reference 4113 Split-Seconds Chronograph to Headline FutureGrail Online Auction
SINGAPORE, Nov. 4, 2025 /PRNewswire/ -- FutureGrail today announced that the Rolex Reference 4113 "anti-magnetic" split-seconds chronograph (serial number 051 319) in its collection will headline the firm's online auction (8–14 November, 2025)....
Blood Publishes Promising Results of IASO Bio's Anti-GPRC5D CAR-T RD118 in Relapsed/Refractory Multiple Myeloma
SHANGHAI, NANJING, China and PLEASANTON, Calif., Oct. 22, 2025 /PRNewswire/ -- IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company focused on the discovery, development, production, and commercialization of novel cell therapies, today...
JOY GROUP Completes Acquisition of Italian Dermatological Hair Care Brand Foltène
SHANGHAI, Oct. 21, 2025 /PRNewswire/ -- China's leading multi-brand beauty group JOY GROUP (Shanghai Juyi Cosmetics Co., Ltd.) has announced the completion of its acquisition of Foltene, a dermatological hair care brand from Italy. Products of...
Cell Publishes Breakthrough Research Results of IASO Bio's Anti-BCMA CAR-T Equecabtagene Autoleucel in Autoimmune Disease Multiple Sclerosis
SHANGHAI, NANJING, China and PLEASANTON, Calif., Oct. 16, 2025 /PRNewswire/ -- IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovative cell therapies,...
HJT Everywhere: Huasun Demonstrates Flexible PV Integration from Balconies to Electric Vehicles at SNEC 2025
SHANGHAI, June 18, 2025 /PRNewswire/ -- Huasun Energy, the world's leading heterojunction (HJT) solar technology provider, launched three astonishing new products to push the limits of solar application on the first day of SNEC PV Power Expo 2025 in...
Teva and Fosun Pharma Enter into a Strategic Partnership to Develop Novel Anti-PD1-IL2 Therapy (TEV-56278) in Immuno-Oncology
Teva-engineered TEV-56278 is an anti-PD1-IL2 ATTENUKINE™ therapy in Phase 1 for the treatment of various forms of cancer, including melanoma Fosun Pharma-Teva collaboration agreement established with goal of accelerating clinical data generation for...
TCL Solar Showcases Next-Gen BC Modules at SNEC, Writing the Future of Solar Innovation with Technological Advancements
SHANGHAI, June 13, 2025 /PRNewswire/ -- From June 11th to 13th, the 18th International Solar Photovoltaic and Smart Energy Conference & Exhibition (SNEC PV+ 2025) was held at the National Exhibition and Convention Center in Shanghai. During the...
The GrowHub Announces Expansion of Research & Development Team to Accelerate AI Development and Capabilities
SINGAPORE, June 4, 2025 /PRNewswire/ -- THE GROWHUB LIMITED ("The GrowHub" or the "Company"), a Singapore-based company leveraging blockchain technology to enhance product traceability and authenticity for products along the entire supply chain,...
The GrowHub Partners with Business Engineers Asia to Deliver its Traceability Solution
SINGAPORE, May 21, 2025 /PRNewswire/ -- THE GROWHUB LIMITED ("The GrowHub" or the "Company"), a Singapore-based company leveraging blockchain technology to enhance product traceability and authenticity, partners with Business Engineers Asia ("BEA")...